T. Pudlarz

695 total citations · 1 hit paper
26 papers, 416 citations indexed

About

T. Pudlarz is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, T. Pudlarz has authored 26 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 7 papers in Pathology and Forensic Medicine and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in T. Pudlarz's work include Colorectal Cancer Treatments and Studies (9 papers), Pancreatic and Hepatic Oncology Research (8 papers) and Genetic factors in colorectal cancer (7 papers). T. Pudlarz is often cited by papers focused on Colorectal Cancer Treatments and Studies (9 papers), Pancreatic and Hepatic Oncology Research (8 papers) and Genetic factors in colorectal cancer (7 papers). T. Pudlarz collaborates with scholars based in France, United States and Vietnam. T. Pudlarz's co-authors include Romain Cohen, Thierry André, Christelle de la Fouchardière, David Tougeron, Marie‐Line Garcia‐Larnicol, Magali Svrcek, Christophe Tournigand, Christophe Louvet, Julie Henriques and Astrid Lièvre and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

T. Pudlarz

23 papers receiving 412 citations

Hit Papers

Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolu... 2022 2026 2023 2024 2022 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability–High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study
    2022 220 citations Thierry André, David Tougeron et al. Journal of Clinical Oncology profile →

Peers

T. Pudlarz
Sanna Hulkki-Wilson United Kingdom
Sabina Murgioni Italy
K.-W. Lee South Korea
Floriana Nappo Italy
Markus Moehler Germany
Syoichi Fujii Japan
Hideo Baba Japan
Lorenzo De Franco Italy
Leila Sisic Germany
Masashi Fujii Japan
Sanna Hulkki-Wilson United Kingdom
T. Pudlarz
Citations per year, relative to T. Pudlarz T. Pudlarz (= 1×) peers Sanna Hulkki-Wilson

Countries citing papers authored by T. Pudlarz

Since Specialization
Citations

This map shows the geographic impact of T. Pudlarz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Pudlarz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Pudlarz more than expected).

Fields of papers citing papers by T. Pudlarz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Pudlarz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Pudlarz. The network helps show where T. Pudlarz may publish in the future.

Co-authorship network of co-authors of T. Pudlarz

This figure shows the co-authorship network connecting the top 25 collaborators of T. Pudlarz. A scholar is included among the top collaborators of T. Pudlarz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Pudlarz. T. Pudlarz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akoury, Elie, Alina Fuerea, T. Pudlarz, et al.. (2025). Precision medicine strategy in pancreatic ductal adenocarcinoma. ESMO Open. 10(12). 105899–105899.
2.
Hollebecque, Antoine, et al.. (2025). 304P Impact of neoadjuvant and adjuvant strategies on outcomes in non-metastatic pancreatic cancer. Annals of Oncology. 36. S119–S119. 2 indexed citations
3.
Fernandes, Aristi P., Aurélien Lambert, Antoine Hollebecque, et al.. (2024). 338P Heads or tails? In-depth analysis of pancreatic cancer outcomes according to tumour location. Annals of Oncology. 35. S142–S142. 1 indexed citations
4.
Boilève, Alice, Cristina Smolenschi, Aurélien Lambert, et al.. (2024). KRAS, a New Target for Precision Medicine in Colorectal Cancer?. Cancers. 16(20). 3455–3455. 6 indexed citations
5.
Smolenschi, Cristina, M-L. Tanguy, David Malka, et al.. (2024). Pancreatic adenocarcinoma third line systemic treatments: a retrospective cohort study. BMC Cancer. 24(1). 272–272. 3 indexed citations
6.
Vasseur, Damien, Odile Cabaret, Sophie Cotteret, et al.. (2024). Case report: Microsatellite instability determination is not always black and white in Lynch syndrome diagnosis. Frontiers in Oncology. 14. 1396869–1396869. 1 indexed citations
7.
Smolenschi, Cristina, Maximiliano Gelli, Simona Cosconea, et al.. (2024). Clinical and molecular features of early onset pancreatic adenocarcinoma. International Journal of Cancer. 155(11). 1969–1981. 3 indexed citations
8.
Boilève, Alice, Cristina Smolenschi, Aurélien Lambert, et al.. (2024). Role of molecular biology in the management of pancreatic cancer. World Journal of Gastrointestinal Oncology. 16(7). 2902–2914. 1 indexed citations
9.
Lambert, Aurélien, Antoine Hollebecque, Cristina Smolenschi, et al.. (2024). 1516P Lung-only metastatic PDAC: Another disease?. Annals of Oncology. 35. S927–S927.
10.
Delaye, Matthieu, et al.. (2024). Professionals' Perceptions of the Colorectal Cancer Pathway: Results of a Co‐Constructed Qualitative Study. Health Expectations. 27(4). e14146–e14146. 1 indexed citations
11.
Smolenschi, Cristina, Antoine Hollebecque, Alice Boilève, et al.. (2023). PD-29 Could molecular profiling be helpful in daily practice in the treatment of anal carcinoma?. Annals of Oncology. 34. S13–S13. 1 indexed citations
12.
Rémond, Marc, Antoine Hollebecque, Maximiliano Gelli, et al.. (2023). 1667P Clinical and molecular features of young onset pancreatic adenocarcinoma. Annals of Oncology. 34. S917–S917. 1 indexed citations
13.
Nicolle, Rémy, Valérie Boige, T. Pudlarz, et al.. (2023). Precision medicine for KRAS wild-type pancreatic adenocarcinomas. European Journal of Cancer. 197. 113497–113497. 16 indexed citations
14.
Pudlarz, T., et al.. (2023). 172P Early impact of a personalised cancer interception programme for women at non-genetic high risk of breast cancer (BC). ESMO Open. 8(1). 101449–101449. 1 indexed citations
15.
Vasseur, Damien, Alice Boilève, Cristina Smolenschi, et al.. (2023). Targetable Molecular Alterations in the Treatment of Biliary Tract Cancers: An Overview of the Available Treatments. Cancers. 15(18). 4446–4446. 16 indexed citations
16.
André, Thierry, David Tougeron, Guillaume Piessen, et al.. (2022). Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability–High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study. Journal of Clinical Oncology. 41(2). 255–265. 220 indexed citations breakdown →
17.
18.
Hilmi, Marc, Anna Pellat, Aude-Marie Foucaut, et al.. (2020). Nutrition and physical activity professional education in gastrointestinal oncology: a national multidisciplinary survey. BMJ Supportive & Palliative Care. 10(3). 324–330. 8 indexed citations
19.
20.
Cohen, Romain, T. Pudlarz, Marc Hilmi, et al.. (2019). Traitement des cancers colorectaux par immunothérapie : aller au-delà de MSI avec la classification moléculaire (CMS) et la charge mutationnelle. Bulletin du Cancer. 106(2). 151–161. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sanna Hulkki-Wilson Breakdown of academic impact, for papers by Sabina Murgioni Breakdown of academic impact, for papers by K.-W. Lee Breakdown of academic impact, for papers by Floriana Nappo Breakdown of academic impact, for papers by Markus Moehler Breakdown of academic impact, for papers by Syoichi Fujii Breakdown of academic impact, for papers by Hideo Baba Breakdown of academic impact, for papers by Lorenzo De Franco Breakdown of academic impact, for papers by Leila Sisic Breakdown of academic impact, for papers by Masashi Fujii
Rankless by CCL
2026